CN1301267A - 光学活性膦烷的生产 - Google Patents
光学活性膦烷的生产 Download PDFInfo
- Publication number
- CN1301267A CN1301267A CN99806300A CN99806300A CN1301267A CN 1301267 A CN1301267 A CN 1301267A CN 99806300 A CN99806300 A CN 99806300A CN 99806300 A CN99806300 A CN 99806300A CN 1301267 A CN1301267 A CN 1301267A
- Authority
- CN
- China
- Prior art keywords
- nmr
- alkane
- alkyl
- aryl
- cdcl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title description 2
- 150000004850 phospholanes Chemical class 0.000 title description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 27
- 125000003118 aryl group Chemical group 0.000 claims abstract description 9
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 5
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 4
- 125000002877 alkyl aryl group Chemical group 0.000 claims abstract description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 3
- 125000004437 phosphorous atom Chemical group 0.000 claims abstract description 3
- -1 phosphine alkane Chemical class 0.000 claims description 29
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Natural products P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims description 22
- 229910000073 phosphorus hydride Inorganic materials 0.000 claims description 20
- 150000001875 compounds Chemical class 0.000 claims description 13
- 239000001257 hydrogen Substances 0.000 claims description 12
- 150000004696 coordination complex Chemical class 0.000 claims description 11
- 229910052703 rhodium Inorganic materials 0.000 claims description 11
- VURFVHCLMJOLKN-UHFFFAOYSA-N Diphosphine Natural products PP VURFVHCLMJOLKN-UHFFFAOYSA-N 0.000 claims description 10
- 238000005984 hydrogenation reaction Methods 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
- 229910052707 ruthenium Inorganic materials 0.000 claims description 6
- 238000009876 asymmetric hydrogenation reaction Methods 0.000 claims description 5
- 125000004429 atom Chemical group 0.000 claims description 5
- 150000002431 hydrogen Chemical group 0.000 claims description 5
- 229910052698 phosphorus Inorganic materials 0.000 claims description 5
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 claims description 4
- 229910052741 iridium Inorganic materials 0.000 claims description 3
- 238000006317 isomerization reaction Methods 0.000 claims description 3
- 229910052759 nickel Inorganic materials 0.000 claims description 3
- 229910052763 palladium Inorganic materials 0.000 claims description 3
- 229910052697 platinum Inorganic materials 0.000 claims description 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 2
- 150000002081 enamines Chemical class 0.000 claims description 2
- 238000005669 hydrocyanation reaction Methods 0.000 claims description 2
- 238000007037 hydroformylation reaction Methods 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 239000003054 catalyst Substances 0.000 abstract description 4
- 238000011914 asymmetric synthesis Methods 0.000 abstract description 3
- 101710133727 Phospholipid:diacylglycerol acyltransferase Proteins 0.000 abstract 11
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 27
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 239000000243 solution Substances 0.000 description 19
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 18
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 15
- 239000010948 rhodium Substances 0.000 description 15
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 12
- 238000005160 1H NMR spectroscopy Methods 0.000 description 12
- 239000003446 ligand Substances 0.000 description 12
- 239000006188 syrup Substances 0.000 description 11
- 235000020357 syrup Nutrition 0.000 description 11
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 10
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 10
- 238000004679 31P NMR spectroscopy Methods 0.000 description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 7
- 238000004440 column chromatography Methods 0.000 description 7
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 description 4
- 235000011152 sodium sulphate Nutrition 0.000 description 4
- UORVGPXVDQYIDP-UHFFFAOYSA-N trihydridoboron Substances B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 229910000085 borane Inorganic materials 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000008504 concentrate Nutrition 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 229940051250 hexylene glycol Drugs 0.000 description 3
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 3
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- RCLPHCJMHYUGSX-UHFFFAOYSA-N B.CC Chemical compound B.CC RCLPHCJMHYUGSX-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical group OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229950005499 carbon tetrachloride Drugs 0.000 description 2
- 229940125797 compound 12 Drugs 0.000 description 2
- 229940126214 compound 3 Drugs 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- AZHPCFQBBJISDG-UHFFFAOYSA-N ethyl(oxido)phosphanium Chemical compound CC[PH2]=O AZHPCFQBBJISDG-UHFFFAOYSA-N 0.000 description 2
- 125000000654 isopropylidene group Chemical group C(C)(C)=* 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 150000003003 phosphines Chemical class 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 description 1
- 229910020366 ClO 4 Inorganic materials 0.000 description 1
- 235000002492 Rungia klossii Nutrition 0.000 description 1
- 244000117054 Rungia klossii Species 0.000 description 1
- 239000012327 Ruthenium complex Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- DSVGQVZAZSZEEX-UHFFFAOYSA-N [C].[Pt] Chemical compound [C].[Pt] DSVGQVZAZSZEEX-UHFFFAOYSA-N 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 229940125758 compound 15 Drugs 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000012973 diazabicyclooctane Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000002715 modification method Methods 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 125000005328 phosphinyl group Chemical group [PH2](=O)* 0.000 description 1
- GWLJTAJEHRYMCA-UHFFFAOYSA-N phospholane Chemical compound C1CCPC1 GWLJTAJEHRYMCA-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 150000003304 ruthenium compounds Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- MHYGQXWCZAYSLJ-UHFFFAOYSA-N tert-butyl-chloro-diphenylsilane Chemical compound C=1C=CC=CC=1[Si](Cl)(C(C)(C)C)C1=CC=CC=C1 MHYGQXWCZAYSLJ-UHFFFAOYSA-N 0.000 description 1
- ZWZVWGITAAIFPS-UHFFFAOYSA-N thiophosgene Chemical compound ClC(Cl)=S ZWZVWGITAAIFPS-UHFFFAOYSA-N 0.000 description 1
- BDZBKCUKTQZUTL-UHFFFAOYSA-N triethyl phosphite Chemical compound CCOP(OCC)OCC BDZBKCUKTQZUTL-UHFFFAOYSA-N 0.000 description 1
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/18—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
- B01J31/1845—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing phosphorus
- B01J31/1875—Phosphinites (R2P(OR), their isomeric phosphine oxides (R3P=O) and RO-substitution derivatives thereof)
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/22—Organic complexes
- B01J31/2282—Unsaturated compounds used as ligands
- B01J31/2295—Cyclic compounds, e.g. cyclopentadienyls
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
- B01J31/2404—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
- B01J31/2419—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring comprising P as ring member
- B01J31/2423—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring comprising P as ring member comprising aliphatic or saturated rings
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
- B01J31/2404—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
- B01J31/2419—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring comprising P as ring member
- B01J31/2428—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring comprising P as ring member with more than one complexing phosphine-P atom
- B01J31/2433—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring comprising P as ring member with more than one complexing phosphine-P atom comprising aliphatic or saturated rings
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
- B01J31/2404—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
- B01J31/2442—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring comprising condensed ring systems
- B01J31/2461—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring comprising condensed ring systems and phosphine-P atoms as ring members in the condensed ring system or in a further ring
- B01J31/2471—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring comprising condensed ring systems and phosphine-P atoms as ring members in the condensed ring system or in a further ring with more than one complexing phosphine-P atom
- B01J31/2476—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring comprising condensed ring systems and phosphine-P atoms as ring members in the condensed ring system or in a further ring with more than one complexing phosphine-P atom comprising aliphatic or saturated rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B53/00—Asymmetric syntheses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0073—Rhodium compounds
- C07F15/008—Rhodium compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6568—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6568—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus atoms as the only ring hetero atoms
- C07F9/65683—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus atoms as the only ring hetero atoms the ring phosphorus atom being part of a phosphine
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/30—Addition reactions at carbon centres, i.e. to either C-C or C-X multiple bonds
- B01J2231/32—Addition reactions to C=C or C-C triple bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/40—Substitution reactions at carbon centres, e.g. C-C or C-X, i.e. carbon-hetero atom, cross-coupling, C-H activation or ring-opening reactions
- B01J2231/44—Allylic alkylation, amination, alkoxylation or analogues
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/50—Redistribution or isomerisation reactions of C-C, C=C or C-C triple bonds
- B01J2231/52—Isomerisation reactions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/60—Reduction reactions, e.g. hydrogenation
- B01J2231/64—Reductions in general of organic substrates, e.g. hydride reductions or hydrogenations
- B01J2231/641—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes
- B01J2231/645—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes of C=C or C-C triple bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/821—Ruthenium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/822—Rhodium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/824—Palladium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/827—Iridium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/828—Platinum
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/84—Metals of the iron group
- B01J2531/847—Nickel
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Glass Compositions (AREA)
Abstract
本发明涉及通式(I)的膦烷及二膦烷,其中:R代表氢、C1~C6—烷基、芳基、烷芳基、SiR3 2;R2代表烷基或芳基;A代表氢、C1~C6—烷基、芳基、C1或者(a);以及B代表2个磷原子之间的1~5个碳原子的连接基。本发明还涉及所述膦烷及二膦烷作为催化剂在不对称合成中的应用。
Description
本发明描述新型光学活性膦烷(phospholane)及双磷烷,其制备及其作为金属络合物中配位体的应用,以及该金属络合物在对映体选择性合成中的应用。
涉及铑及钌络合物的对映体选择性氢化及异构化,在光学活性化合物的合成中占有非常重要的地位(例如参见,Tani等人,《美国化学学会会报》106,5211,1984;R.Noyori,《美国化学研究报告》23,345(1990))。化学计量的原料氢虽然花费很少,但是所采用的催化剂,大多由光学活性二膦配位体及铑或钌化合物制备,却成本非常高,且只能通过复杂方式制取。
光学活性膦及二膦的已知制备方法全都很复杂并且一般都包括技术上繁杂、成本高昂的外消旋拆分(例如,EP-A0614901、EP-A0271311;H.B.Kagan,“不对称催化中的手性配位体”,《不对称合成》,卷5(1985),pp.13~23;EP-A0151282、EP-A 0185882;R.Noyori,《美国化学研究报告》23,345(1990);EP-269395;M.J.Burk,《四面体.不对称》,pp.569~592(1991);《美国化学学会会报》113,pp.8518-9(1991);同一出处,115,pp.10125~138(1993);同处,117,pp.9375~76(1995);同处,118,pp.5142(1996))。这些缺陷使其在工业应用起来困难而且不经济。
本发明的目的是提供一种膦配位体,它容易制备且成本低,而且是对映体选择性合成金属络合物催化剂用的优良配位体。
我们发现,这一目的可由一类特别高效的配位体,主要是膦烷,来实现,这类配位体可由其“手性资源”获得。这种情况下的原料是甘露糖醇以及其他可低成本地大量制取的碳水化合物。
生成的膦烷及二膦烷可在不对称氢化中提供极好的对映体过量。Burk等人的已知DUPHOS配位体(M.J.Burk,《四面体·不对称》,pp.569~592(1991);《美国化学学会会报》113,pp.8518-9(1991);同一出处,115,pp.10125~138(1993);同处,117,pp.9375~76(1995);同处,118,pp.5142(1996);US5,008,457、WO92/19630、WO93/19040),与本发明相比,合成起来非常繁琐。DUPHOS配位体的合成,除了不对称氢化之外还要求,尤其是难以实现的电解Kolbe(科尔伯)合成。
本发明由于采用天然来源对映体纯级的糖类甘露糖醇,故避免了这些困难。另外,这种前体还可为获得在膦烷环的2和5位上具有烷氧甲基或羟甲基基团的化合物提供途径。这种类型的化合物无法通过已知的DUPHOS合成来制备。
R是氢、C1~C6-烷基、芳基、烷芳基,SiR3 2,
R2是烷基或芳基,
B是2个磷原子之间的1~5个碳原子的连接基。
优选的取代基R是氢、甲基、乙基、正丙基、异丙基、正丁基、异丁基、叔丁基、苄基、trityl及三烷基甲硅烷基或三芳基甲硅烷基
(SiR3 2,其中R2=C1~C6-烷基或芳基)。
R3=烷基或稠合芳基
尤其优选的连接基B是结构式中n等于1或2且m是0的那些。
本发明还涉及包含上述膦烷的金属络合物,其中中心原子选自Rh、Ru、Ir、Pd、Pt、Ni。
尤其优选的金属络合物是包含钌或铑作为中心原子的那些。
这些络合物可这样来制备,即,按已知方法(例如,Uson,《无机化学学报》73,275(1983);EP-A 0158875、EP-A 437690)通过与包含易变配位体的铑、铱、钌、钯、铂或镍络合物(例如,{RuCl2(COD)]n、Rh(COD)2BF4、Rh(COD)2ClO4、[Ir(COD)Cl]2、氯化对散花-钌二聚体)之间的反应来合成该催化活性络合物。
本发明还涉及这些金属络合物在不对称合成中的应用,尤其是作为氢化、加氢甲酰基化、氢氰化、烯丙基取代以及由烯丙基胺到烯胺的异构化等的催化剂。
这类反应可借助本发明的金属络合物在本领域技术人员熟悉的条件下进行。
借助本发明金属络合物的氢化通常在-20~150℃,优选0~100℃,尤其优选15~40℃的温度进行。
按照本发明的氢化方法的氢气压力可在0.1bar~300bar的宽范围变化。非常好的结果可在1~10,优选1~2bar范围的压力下获得。
采用本发明配位体尤其有利之处在于, 氢化可在1~2bar氢气低压力下非常高效地实施。
优选的氢化溶剂是C1~C4-链烷醇,尤其是甲醇。在被作用物溶解度低的情况下,溶剂混合物如甲醇与CH2Cl2,或THF、甲苯等也是合适的。
催化剂的用量,以待氢化被作用物为基准,一般介于0.001~5mol%,优选0.001~0.01mol%。
1,2;5,6-二-O-异丙叉-3,4-O-硫代羰基-D-甘露糖醇(1):
采用E.J.Corey等人的方法1,使1,2;5,6-二-O-异丙叉-D-甘露糖醇与硫光气在4-二甲氨基吡啶存在下、在二氯甲烷中进行反应,收率为90%。
E-3,4-二脱氢-3,4-二脱氧-1,2;5,6-二-O-异丙叉-D-苏-己糖醇(2):
环状硫代碳酸酯1,按文献2,3在亚磷酸三乙酯中加热20h,生成反式-烯烃,收率为80~90%。
3,4-二脱氧-1,2;5,6-二-O-异丙叉-D-苏-己糖醇(3):
按Machinaga等人方法4的改良方法,烯烃2(10g)在甲醇中、10%活性炭载铂(250mg)的存在、大气压压力下氢化生成化合物3。经柱色谱术提纯后,收率为80~90%。化合物3还可按照文献4通过蒸馏进行提纯(沸点0.6mm=73℃)。
3,4-二脱氧-D-苏-己糖醇(4):
按照文献4,异丙叉基团在1N盐酸中发生酸解。生成的化合物经过重结晶以后获得的收率为85%。
(2S,5S)-1,6-双(苄氧基)-2,5-己二醇(5):
3.0g(20mmol)3,4-二脱氧-D-苏-己糖醇(4)按Marzi等人的方法5,转化为3.70g 1,6-二-O-苄基化产物5,收率为56%。
(2S,5S)-1,6-双[(叔丁基二苯基甲硅烷基)氧基]-2,5-己二醇(6):
3.0g(20mmol)化合物4与叔丁基二苯基氯硅烷在DMF中、咪唑存在下按文献5起反应生成衍生物6,收率为80%。
(4S,7S)-4,7-双(苄氧基甲基)-2,2-二氧代[1,3,2]-dioxo-thiepane(7):
1.43g(12mmol)亚硫酰氯在氩气氛下缓慢地加入到3.30g(10mmol)二醇5在70mL干燥四氯甲烷中的体系中, 然后混合物回流90min。在旋转蒸发器中赶出溶剂以后,残余物溶解在四氯甲烷(40mL)、乙腈(40mL)及水(60mL)的混合物中,然后在0℃下,加入15mg(72μmol)RuCl3*3H2O及4.28g(20mmol)高碘酸钠。然后混合物在室温搅拌1h,继而在悬浮体中加入50mL水。随后以二乙醚(3×75mL)萃取并以饱和氯化钠溶液(100mL)洗涤有机相,然后干燥(硫酸钠),形成的残渣经过柱色谱术处理(正已烷∶乙酸乙酯=2∶1,Rf=0.20)给出化合物7,收率3.37g(86%)。
熔点=57to 59℃;[α]D 26=-37.2°(c1.01;CHCl3);1H-NMR(CDCl3,400MHz)δ7.34(10H,m,arom.H),4.78(2H,m,H-2/5),4.57(2H,AB-sp.,Ha-CH2Ph,2Ja,b=12.0Hz),4.56(2H,AB-sp.,Hb-CH2Ph,2Ja,b=12.0Hz),3.65(2H,dd,Ha-CH2OH,2Ja,b=10.8Hz,3JH,H=5.4Hz),3.56(2H,dd,Hb-CH2OH,2Ja,b=10.8Hz,3JH,H=4.9Hz),2.00(4H,m,H-3/4);13C-NMR(CDCl3,100MHz)δ137.3,128.4-127.7(arom.C),82.6(C-2/5),73.4(CH2Ph),70.8(C-1/6),28.9(C-3/4);元素分析C20H24O6S(392.47)计算值:C61.21,H6.16,S8.17;测定值:C61.03,H6.19,S8.10;
1,6-二-O-(叔丁基二苯基)甲硅烷基-2,5-O-异丙叉-3,4-二脱氧-D-苏-己糖醇(8):
6.27g(10mmol)化合物6按文献5转化为异丙叉衍生物8,收率85%(5.67g)。8用柱色谱术提纯(正己烷∶二乙醚=19∶1,Rf=0.2),以便鉴定。若用于下一步反应, 则该化合物不需要提纯。
2,5-O-异丙叉-3,4-二脱氧-D-苏-己糖醇(9):
6.67g(10mmol)甲硅烷基化合物8借助氟化四丁铵溶于THF的溶液脱除甲硅烷基基团5,随后色谱提纯(二乙醚∶甲醇=19∶1,Rf=0.5),生成1.7g(89%)二醇9。
2,5-O-异丙叉-1,6-二-O-甲基-3,4-二脱氧-D-苏-己糖醇(10):
3.80g(20mmol)二醇9溶于30mL THF的溶液在0℃加入到1.06g(44mmol)NaH溶于60mL THF的溶液中。醇盐生成反应完成之后,慢慢加入2.2当量碘甲烷(6.21g,44mmol),混合物在室温搅拌。反应完成之后,以水(30mL)小心地将过量NaH分解,然后在减压下赶出THF。然后,以二氯甲烷(3×50毫升)萃取剩余水溶液,干燥(硫酸钠)合并的有机相。浓缩后获得的残渣经柱色谱术(正己烷∶乙酸乙酯=2∶1,Rf=0.40)获得无色糖浆,收率84%(3.68g)。糖浆;[α]D 23=-32.8°(c1.01,CHCl3);1H-NMR(CDCl3,400MHz)δ3.92(2H,m,H-2/5),3.32(2H,dd,Ha-CH2O,2Ja,b=9.9Hz,3JH,H=6.3Hz),3.30(6H,s,CH3),3.55(2H,m,Hb-CH2O,2Ja,b=9.9Hz,3JH,H=5.3Hz),1.67(2H,m,Ha-3/4),1.34(2H,m,Hb-3/4),1.31(6H,s,CH3);13C-NMR(CDCl3,100MHz)δ100.5(C(O)2),76.2(C-1/6),70.4(C-2/5),59.1(CH3),31.1(C-3/4),25.6(C(CH3)2);
元素分析C11H22O4(218.293)计算值:C60.52,H10.16;测定值:C60.38,H10.07;
(2S,5S)-1,6-双(苄氧基)-2,5-己二醇(11):
4.0g(18.32mmol)化合物10在60mL THF与60mL 1N盐酸混合物中水解20min。溶液在旋转蒸发器中浓缩之后,经色谱术(乙醇∶乙酸乙酯=1∶3,Rf=0.45)处理生成3.20g浅黄色糖浆11,收率几乎达到定量水平。糖浆;[α]D 22=-7.2°(c1.09,CH3OH);1H-NMR(CD3OD,400MHz)δ3.72(2H,m,H-2/5),3.37(6H,s,CH3),3.38-3.30(4H,m,CH2OH),1.56(4H,m,H-3/4);13C-NMR(CD3OD,100MHz)δ78.2(C-1/6),70.1(C-2/5),59.2(CH3),30.6(C-3/4);元素分析C8H18O4(178.228)计算值:C53.91,H10.18;测定值:C53.47,H10.14;
(4S,7S)-4,7-双(甲氧基甲基)-2,2-二氧代[1,3,2]-dioxo-thiepane(12):
1.78g(10mmol)二醇11按类似于环状硫酸酯7的制备转化为目标化合物12。这种情况下,也可不实施色谱术(正己烷∶乙酸乙酯=1∶2,Rf=0.4)的提纯步骤,因为,产物12可通过结晶从二乙醚/正己烷中以白色固体形式分离出来,收率76%(1.83g)。
熔点=75-78℃;[α]D 23=-44.1°(c1.01;CHCl3);1H-NMR(CDCl3,400MHz)δ4.72(2H,m,H-2/5),3.56(2H,dd,Ha-CH2O,2Ja,b=10.8Hz,3JH,H=5.4Hz),3.47(2H,dd,Ha-CH2O,2Ja,b=10.8Hz,3JH,H=4.7Hz),3.37(6H,s,CH3),2.04-1.92(4H,m,H-3/4);13C-NMR(CDCl3,100MHz)δ82.5(C-2/5),73.4(C-1/6),59.3(OCH3),28.8(C-3/4);元素分析C8H16O6S(240.274)计算值:C39.99,H6.71,S13.34;测定值:C40.06,H6.76,S1.27;
1,2-双[(2R,5R)-2,5-苄氧基甲基膦烷基(phospholanyl)]苯(13):
2.0当量正丁基锂(4.58mL,1.6M正己烷中的溶液)慢慢加入到0.52g(3.66mmol)1,2-双(氧膦基)-苯溶于50mL THF的溶液中,2h后,在所形成的黄色溶液中慢慢加入2.86g(7.32mmol)环状硫酸酯7溶于20mL THF的溶液。混合物在室温再搅拌2h,最后,再次加入2.2当量正丁基锂(5.03mL,1.6M溶于正己烷的溶液)。溶液搅拌过夜,最后以2mL甲醇破坏多余的正丁基锂。减压下赶出溶剂,残余物在绝氧条件下溶于20mL水中并以二氯甲烷萃取(2×50mL)。有机相干燥(硫酸钠)后,赶出溶剂。利用柱色谱术(正己烷∶乙酸乙酯=4∶1,Rf=0.35)分离出要求的产物,获得0.52g(19%)浅黄色糖浆。糖浆;1H-NMR(CDCl3,400MHz)δ7.45-7.10(24H,m,arom,H),4.49(2H,AB-sp.,Ha-CH2Ph,2Ja,b=12.1Hz),4.47(2H,AB-sp.,Hb-CH2Ph,2Ja,b=12.1Hz),4.18(2H,AB-sp.,Ha-CH2Ph,2Ja,b=11.9Hz),4.04(2H,AB-sp.,Hb-CH2Ph,2Ja,b=11.9Hz),3.65-3.45(4H,m,CH2O),2.97-2.80(4H,m,CH2O),2.70(2H,m,CH-P);2.33(4H,m,CH-P,Ha-(CH2)2);2.18(2H,m,Ha-(CH2)2),1.80-1.53(4H,m,Hb-(CH2)2);13C-NMR(CDCl3,100MHz)δ141.8(m,Car-P),138.6+138.5(ipso-C),131.8,128.4-127.1(arom.C),74.1(m,CH2Ph),73.0(CH2Ph),72.5(CH2O),72.5(CH2O),39.5(CH-P),38.9(m,CH-P),30.9(CH2),30.4(CH2);31P-NMR(CDCl3,162MHz)δ11.5;
1,2-双[(2R,5R)-2,5-甲氧基甲基膦烷基]苯(14):
按类似于双磷烷13的制备,以化合物12替代环状硫酸酯7起反应,生成要求的甲氧基甲基-取代的双膦烷14。按柱色谱术进行提纯和分离(正己烷∶乙酸乙酯=2∶1,Rf=0.20),获得0.80g(48%)无色糖浆。糖浆;1H-NMR(CDCl3,400MHz)δ7.45(2H,m,arom.H),7.30(2H,m,atom.H),3.55(4H,m,CH2O),3.36(2H,m,CH2O),3.35(6H,s,CH3),3.10(6H,s,CH3),2.90(2H,m,CH2O),2.78(2H,m,CH-P),2.63(2H,m,CH-P),2.32(2H,m,CH2);2.16(4H,m,CH2);1.68(2H,m,CH2),1.55(4H,m,CH2);13C-NMR(CDCl3,100MHz)δ141.9(m,Car-P),131.8,128.4(arom.C),74.1(m,CH2Ph),76.6(m,CH2O),74.5(CH2O),58.8(CH3),58.2(CH3),39.6(CH-P),39.0(m,CH-P),30.9(CH2),30.3(CH2);31P-NMR(CDCl3,162MHz)δ-11.7;
1,2-双[(2R,5R)-2,5-苄氧基甲基膦烷基]乙烷·硼烷络合物(15):
7.40mmol(4.63mL)1.6M正丁基锂/己烷溶液,在室温下加入到348mg(3.70mmol)双(氧膦基)乙烷/THF溶液中。混合物搅拌2h。然后,慢慢加入2.90g(7.40mmol)环状硫酸酯7溶于20mL THF的溶液,混合物再搅拌2h。随后,再加入5.09mL(8.14mmol)正丁基锂溶液,搅拌过夜后反应便告完成。为生成硼烷加成产物,溶液冷却至-20℃,然后加入9.25mL(9.25mmol)1M BH3/THF溶液。2h后,加入2mL甲醇以破坏多余丁基锂及BH3,减压下赶出溶剂。残余物溶解在水中,然后以二氯甲烷萃取。随后,萃取液进行干燥(硫酸钠)并浓缩,残余物通过柱色谱术(正己烷∶乙酸乙酯=4∶1,Rf=0.20)提纯。获得350mg(13%)粘稠糖浆。糖浆;1H-NMR(CDCl3,400MHz)δ7.37-7.22(20H,m,arom.H),4.47(2H,AB-sp.,Ha-CH2Ph,2Ja,b=11.2Hz),4.42(2H,AB-sp.,Ha-CH2Ph,2Ja,b=12.1Hz),4.41(2H,AB-sD.,Hb-CH2Ph,2Ja,b=12.1Hz),4.38(2H,AB-sp.,Hb-CH2Ph,2Ja,b=11.2Hz),3.58(4H,m,CH2O),3.43(4H,m,CH2O),2.37(2H,m,CH-P);2.14-1.79(10H,m,CH-P,(CH2)2),1.41-1.20(2H,m,(CH2)2),0.85-0.00(6H,m,BH3);13C-NMR(CDCl3,100MHz)δ138.1+137.9(ipso-C),128.3-127.4(arom.C),73.2(CH2Ph),72.7(CH2Ph),69.4(CH2O),68.4(CH2O),39.5(m,CH-P),29.1(CH2),28.6(CH2),15.9(m,CH2)2);31P-NMR(CDCl3,162MHz)δ40.2;
1,2-双[(2R,5R)-2,5-甲氧基甲基膦烷基]乙烷·硼烷络合物(16):
2.14g(8.91mmol)环状硫酸酯12与0.42g(4.45mmol)双(氧膦基)乙烷按类似于化合物15的制备起反应生成要求的硼烷保护的双膦烷16。以色谱术提纯,其中正己烷∶乙酸乙酯=2∶1(Rf=0.15)。获得结晶产物,收率0.71g(39%)。
熔点=45-48℃;[α]D 23=21.9°(c1.00;CHCl3);1H-NMR(CDCl3,400MHz)δ3.51(8H,m,CH2O),3.33(6H,s,CH3O),3.32(6H,m,CH3O),2.36(2H,m,CH-P);2.23-2.05(6H,m,CH-P,(CH2)2),1.96(4H,m,CH2)2),1.58-1.35(4H,m,(CH2)2),0.95-0.00(6H,m,BH3);13C-NMR(CDCl3,100MHz)δ71.6(m,CH2O),70.8(CH2O),58.7(CH3O),58.7(CH3O),39.5(m,CH-P),29.1(CH2),28.9(CH2),15.8(m,CH2)2);31P-NMR(CDCl3,162MHz):δ40.5;MS(m/z;EI)391[M+-BH4](100);
1,2-双[(2R,5R)-2,5-甲氧基甲基膦烷基]乙烷(17):
0.30g(0.42mmol)硼烷络合物15在40℃与0.142g(1.26mmol)DABCO溶于6mL甲苯的绝氧溶液进行混合。反应完成之后,溶液浓缩并经过快速柱色谱术(正己烷∶乙酸乙酯=4∶1,Rf=0.55)提纯。获得双膦烷17,收率0.21g(73%),并将其立即用于络合物的制备。糖浆;1H-NMR(CDCl3,400MHz)δ7.35-7.21(20H,m,arom.H),4.52(2H,AB-sp.,Ha-CH2Ph,2Ja,b=12.1Hz),4.48(2H,AB~sp.,Hb-CH2Ph,2Ja,b=12.1Hz),4.43(2H,AB-sp.,Ha-CH2Ph,2Ja,b=12.1Hz),4.41(2H,AB-sp.,Hb-CH2Ph,2Ja,b=12.1Hz),3.61-3.41(8H,m,CH2O),2.29(2H,m,CH-P);2.20(2H,m,CH-P);2.07(4H,m,Ha-(CH2)2),1.53-1.23(8H,m,Hb-(CH2)2),(CH2)2);13C-NMR(CDCl3,100MHz)δ138.6+138.4(ipso-C),128.3-127.3(arom.C),74.2(m,CH2Ph),72.9(CH2Ph),72.7(CH2O),70.2(CH2O),43.7(m,CH-P),40.0(m,CH-P),31.4(CH2),31.3(CH2),19.1(m,CH2)2);31P-NMR(CDCl3,162 MHz):δ-6.9;
[Rh(COD)(P-P)]BF4络合物18、19及20的制备
0.3mmol双膦烷配位体13、14及17溶解在1.5mL THF中,并在-10℃的温度慢慢加入到0.122g(0.3mmol)[Rh(COD)2]BF4在3.5mL THF中的悬浮体中。约10min后,溶液在绝氧条件下过滤以去除不溶解成分, 然后加入15mL二乙醚。这导致分离出橙色沉淀或褐色油状物。滗析掉上层清液,然后以二乙醚洗涤2遍(每遍5mL),减压干燥后获得NMR-光谱纯形式的橙色粉末。[Rh(COD)(13)]BF4(18):收率225mg(73%);1H-NMR(CDCl3,400MHz)δ7.70-6.80(24H,m,arom,H),5.76(2H,m,CHCOD),4.66(2H,m,CHCOD),4.42(2H,AB-sp.,Ha-CH2Ph,2Ja,b=12.3Hz),4.18(2H,AB-sp.,Hb-CH2Ph,2Ja,b=12.3Hz),4.05(2H,AB-sp.,Ha-CH2Ph,2Ja,b=12.9Hz),4.05(2H,AB-sp.,Hb-CH2Ph,2Ja,b=12.9Hz),3.80(2H,m,CH2O),3.60(4H,m,CH2O),3.30(2H,m,CH2O),2.87-1.50(20H,m,4×CH-P,4×(CH2)2);13C-NMR(CDCl3,100MHz)δ140.5(m,Car-P),137.7+137.0(ipso-C),132.3,128.5-127.3(arom.C),107.0(CHCOD),91.9(CHCOD),73.2(m,CH2Ph),73.0(CH2Ph),70.6(m,CH2O),68.1(CH2O),49.7(m,CH-P),42.7(m,CH-P),33.7(CH2),32.1(CH2),31.3(CH2),27.0(CH2);31P-NMR(CDCl3,162MHz):δ64.3(1JRh,p=150Hz);MS(m/z;FABpos)941[M+-BF4](20),833[M+-BF4-COD](100);[Rh(COD)(14)]BF4(19):收率155mg(71%);1H-NMR(CDCl3,400MHz)δ7.74(2H,m,arom.H),7.68(2H,m,arom.H),5.57(2H,m,CHCOD),4.80(2H,m,CHCOD),3.82(2H,m,CH2),3.67(2H,m,CH2),3.50(2H,m,CH2),3.26(6H,s,CH3O),3.13(2H,m,CH2),2.90(2H,m,CH-P),2.85(6H,s,CH3O),2.67-2.27(14H,m,CH-P,(CH2)2),1.94(2H,m,(CH2)2),1.58(2H,m,(CH2)2);13C-NMR(CDCl3,100MHz)δ140.2(m,Car-P),132.4-132.0(arom.C),106.1(m,CHCOD),90.8(m,CHCOD),73.7(m,CH2O),70.8(CH2O),58.8+58.7(CH3O),49.4+42.5(m,CH-P),33.5+31.9+31.2+27.6(CH2);31P-NMR(CDCl3,162MHz):δ65,0(1JRh,P=150Hz);[Rh(COD)(17)]BF4(20):收率190mg(65%);1H-NMR(CDCl3,400MHz)δ7.30-7.05(20H,m,arom.H),5.55(2H,m,CHCOD),4.58(2H,m,CHCOD),4.43-4.20(8H,m,CH2Ph,3.77-3.40(8H,m,CH2O),2.50-1.90(20H,m,CH-P,(CH2)2);1.60-1.20(4H,m,(CH2)2);13C-NMR(CDCl3,100MHz)δ137.9+137.7(ipso-C),128.5-127.2(arom.C),102.1(CHCOD),91.5(CHCOD),73.4+72.1(CH2Ph),72.8(CH2O),68.8(CH2O),45.2+39.2(m,CH-P),32.7(CH2),31.3(CH2),30.0(CH2),27.7(CH2)20.8(m,CH2)2);31P-NMR(CDCl3,162MHz):δ7.3(1JRh,P=147Hz);
参考文献1 E.J.Corey;P.B. Hopkins Tetrahedron Lett.23(1982)1979-1982;2 M.Marzi;D.Misiti Tetrahedron Lett.30(1989)6075-6076;3 A.Haines Carbohydrate Res.1(1965)214-228;4 N.Machinaga;C.Kibayashi J.Org.Chem.57(1992)5178-5189;5 M.Marzi;P.Minetti;D.Misiti Tetrahedron 48(1992)10127-10132;
Claims (9)
2.权利要求1的膦烷,其中R是氢或甲基。
4.权利要求3的二膦烷,其中取代基具有下列含义:
m=0,n=1。
5.一种金属络合物, 包含权利要求1~4中任何一项的膦烷以及选自Rh、Ru、Ir、Pd、Pt、Ni的中心原子。
6.权利要求5的金属络合物,其中选Rh或Ru作为中心原子。
7.权利要求5或6的金属络合物在不对称氢化、加氢甲酰基化、氢氰化、烯丙基取代以及由烯丙基胺到烯胺的异构化方面的应用。
8.一种化合物的不对称氢化方法, 包括待氢化原料化合物与氢气在权利要求5或6的金属络合物存在下进行反应。
9.权利要求8的方法,其中氢化是在1~2bar氢气压力下进行的。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19824121A DE19824121A1 (de) | 1998-05-29 | 1998-05-29 | Herstellung optisch aktiver Phospholane, deren Metallkomplexe und Anwendung in der asymmetrischen Synthese |
DE19824121.6 | 1998-05-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1301267A true CN1301267A (zh) | 2001-06-27 |
CN1152884C CN1152884C (zh) | 2004-06-09 |
Family
ID=7869348
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB998063002A Expired - Fee Related CN1152884C (zh) | 1998-05-29 | 1999-05-28 | 光学活性膦烷的生产 |
Country Status (9)
Country | Link |
---|---|
US (1) | US6632953B1 (zh) |
EP (1) | EP1082328B1 (zh) |
JP (1) | JP4465110B2 (zh) |
CN (1) | CN1152884C (zh) |
AT (1) | ATE228139T1 (zh) |
CA (1) | CA2333888C (zh) |
DE (2) | DE19824121A1 (zh) |
ES (1) | ES2188176T3 (zh) |
WO (1) | WO1999062917A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2236134T3 (es) | 2000-12-13 | 2005-07-16 | Warner-Lambert Company Llc | Ligandos bisfosfolanos p-quirales y sus complejos con metales de transicion. |
MXPA02001147A (es) | 2001-03-19 | 2004-04-21 | Warner Lambert Co | Sintesis de ligandos bisfosina no-c2-simetricos como catalizadores para la hidrogenacion asimetrica. |
CN100349907C (zh) * | 2003-05-09 | 2007-11-21 | 索尔维亚斯股份公司 | 膦烷盐及其在对映选择性氢化中的用途 |
EP1864990A1 (en) * | 2006-06-01 | 2007-12-12 | Universität Wien | Preparation of secondary phosphines |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3803225A (en) * | 1971-06-01 | 1974-04-09 | Upjohn Co | 1-halophospholenes |
DE3403774A1 (de) | 1984-02-03 | 1985-08-08 | Anton Hummel Gmbh Metallwarenfabrik, 7808 Waldkirch | Winkelfoermige leitungseinfuehrung |
DE3446303A1 (de) | 1984-12-19 | 1986-06-19 | Degussa Ag, 6000 Frankfurt | Verfahren zur herstellung von optisch aktivem 1-benzyl-3,4-bis-(diphenylphosphino)-pyrrolidin |
JPS63135397A (ja) | 1986-11-27 | 1988-06-07 | Takasago Corp | ルテニウム−ホスフイン錯体 |
JPS63145291A (ja) | 1986-12-09 | 1988-06-17 | Takasago Corp | ルテニウム−ホスフイン錯体 |
US5008457A (en) * | 1990-05-17 | 1991-04-16 | E. I. Du Pont De Nemours And Company | Chiral phospholane transition metal catalysts |
US5202493A (en) * | 1991-04-26 | 1993-04-13 | E. I. Du Pont De Nemours And Company | Chiral tridentate bis(phospholane) ligands |
US5268275A (en) | 1991-05-08 | 1993-12-07 | The University Of North Carolina At Chapel Hill | Vitamin K-dependent carboxylase |
US5250731A (en) | 1992-03-17 | 1993-10-05 | E. I. Du Pont De Nemours And Company | Preparation of optically active hydrazines and amines |
JP3313805B2 (ja) | 1993-03-12 | 2002-08-12 | 高砂香料工業株式会社 | ホスフィン化合物およびこれを配位子とする遷移金属−ホスフィン錯体 |
DE19725796A1 (de) * | 1997-06-18 | 1998-12-24 | Basf Ag | Herstellung optisch aktiver Phospholane, deren Metallkomplexe und Anwendung in der asymmetrischen Synthese |
-
1998
- 1998-05-29 DE DE19824121A patent/DE19824121A1/de not_active Withdrawn
-
1999
- 1999-05-28 DE DE59903471T patent/DE59903471D1/de not_active Expired - Lifetime
- 1999-05-28 EP EP99926460A patent/EP1082328B1/de not_active Expired - Lifetime
- 1999-05-28 AT AT99926460T patent/ATE228139T1/de not_active IP Right Cessation
- 1999-05-28 US US09/700,521 patent/US6632953B1/en not_active Expired - Fee Related
- 1999-05-28 CN CNB998063002A patent/CN1152884C/zh not_active Expired - Fee Related
- 1999-05-28 JP JP2000552128A patent/JP4465110B2/ja not_active Expired - Fee Related
- 1999-05-28 ES ES99926460T patent/ES2188176T3/es not_active Expired - Lifetime
- 1999-05-28 WO PCT/EP1999/003702 patent/WO1999062917A1/de active IP Right Grant
- 1999-05-28 CA CA002333888A patent/CA2333888C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US6632953B1 (en) | 2003-10-14 |
WO1999062917A1 (de) | 1999-12-09 |
CN1152884C (zh) | 2004-06-09 |
DE19824121A1 (de) | 1999-12-02 |
JP4465110B2 (ja) | 2010-05-19 |
CA2333888C (en) | 2008-10-14 |
ATE228139T1 (de) | 2002-12-15 |
EP1082328A1 (de) | 2001-03-14 |
CA2333888A1 (en) | 1999-12-09 |
JP2002517403A (ja) | 2002-06-18 |
ES2188176T3 (es) | 2003-06-16 |
DE59903471D1 (de) | 2003-01-02 |
EP1082328B1 (de) | 2002-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3148136B2 (ja) | 新規なキラルジホスフィン化合物、その製造中間体、該ジホス フィン化合物を配位子とする遷移金属錯体並びに該錯体を含む 不斉水素化触媒 | |
HU217368B (hu) | Királis 2,5-dialkil- foszfolánok, előállításuk és a vegyületeket ligandumként tartalmazó enantioszelektív hidrogénezőkatalizátorok | |
JP4488739B2 (ja) | P−キラルホスホランおよびホスホ環式化合物並びにその不斉触媒反応における使用 | |
CN1292728A (zh) | 含有基于膦酸盐配体的第ⅷ副族金属络合物的催化剂以及加氢甲酰化方法 | |
JP2733880B2 (ja) | 光学活性三級ホスフィン化合物およびこれを配位子とする遷移金属錯体 | |
US20040229846A1 (en) | P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions | |
US5202473A (en) | Ruthenium-binap asymmetric hydrogenation catalyst | |
JP3313805B2 (ja) | ホスフィン化合物およびこれを配位子とする遷移金属−ホスフィン錯体 | |
US6683208B2 (en) | Optically active diphosphines, preparation thereof according to a process for the resolution of the racemic mixture and use thereof | |
JP4427109B2 (ja) | ホスホラン及びジホスホラン、その金属錯体、その使用及び不斉水素化の方法 | |
CN1152884C (zh) | 光学活性膦烷的生产 | |
JP2010053049A (ja) | ジホスフィン化合物、その遷移金属錯体およびその遷移金属錯体を含む触媒並びにホスフィンオキシド化合物及びジホスフィンオキシド化合物 | |
EP0955303A2 (en) | Ruthenium-iodo-optically active phosphine complex | |
JP3789508B2 (ja) | 光学活性非対称ジホスフィン及び該化合物の存在下にて光学活性体を得る方法 | |
JP3441605B2 (ja) | 新規光学活性ジホスフィン及び該化合物より得られる遷移金属錯体及び該錯体の存在下にて光学活性体を得る方法 | |
JP3827017B2 (ja) | ロジウムおよびイリジウムジホスフィナイト炭水化物触媒組成物を用いたデヒドロアミノ酸誘導体の選択的不斉水添 | |
JP3830180B2 (ja) | 新規ホスフィン−ホスフィナイト化合物およびそれを用いた4−[(r)−1’−ホルミルエチル]アゼチジン−2−オン誘導体の製造方法 | |
JP3431749B2 (ja) | 新規な1−置換−2−ジフェニルホスフィノナフタレンおよびこれを配位子とする遷移金属錯体 | |
JP2981621B2 (ja) | ビフェニルビスホスフィン錯体 | |
JP4148702B2 (ja) | 新規なジホスフィン化合物、その製造中間体、該化合物を配位子とする遷移金属錯体並びに該錯体を含む不斉水素化触媒 | |
JP2005518339A (ja) | 対応する(Z)エナミドの鏡像選択的水素化によりエナンチオリッチなN−アシル−β−アミノ酸誘導体の製造方法 | |
JPH06263777A (ja) | ホスフィン化合物およびこれを配位子とする遷移金属−ホスフィン錯体 | |
JPH10139791A (ja) | ルテニウム−光学活性ホスフィン錯体、その製法およびこれを用いた光学活性4−メチル−2−オキセタノンの製造方法 | |
EP1636243B1 (de) | Chirale liganden zur anwendung in asymmetrischen synthesen | |
WO2006088142A1 (ja) | 不斉合成用触媒およびそれに用いる配位子、並びにこれらを用いた不斉合成反応による光学活性化合物の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040609 Termination date: 20110528 |